These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36970217)

  • 1. Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor.
    Shen S; Li T; Fan J; Shao Q; Dong H; Xu X; Mo R
    Acta Pharm Sin B; 2023 Mar; 13(3):1262-1273. PubMed ID: 36970217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
    Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F
    Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.
    Sun R; Liu Y; Li SY; Shen S; Du XJ; Xu CF; Cao ZT; Bao Y; Zhu YH; Li YP; Yang XZ; Wang J
    Biomaterials; 2015 Jan; 37():405-14. PubMed ID: 25453968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells.
    Shen S; Xu X; Lin S; Zhang Y; Liu H; Zhang C; Mo R
    Nat Nanotechnol; 2021 Jan; 16(1):104-113. PubMed ID: 33437035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer.
    Singh D; Singh P; Pradhan A; Srivastava R; Sahoo SK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3670-3685. PubMed ID: 35014452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy.
    Xu C; Li S; Chen J; Wang H; Li Z; Deng Q; Li J; Wang X; Xiong Y; Zhang Z; Yang X; Li Z
    J Control Release; 2023 Apr; 356():256-271. PubMed ID: 36871643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.
    Wong HL; Rauth AM; Bendayan R; Manias JL; Ramaswamy M; Liu Z; Erhan SZ; Wu XY
    Pharm Res; 2006 Jul; 23(7):1574-85. PubMed ID: 16786442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells.
    Huang Y; Zeng F; Xu L; Zhou J; Liu X; Le H
    Oncol Res; 2013; 20(11):499-507. PubMed ID: 24063280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule self-assembled nanodrug for combination therapy of photothermal-differentiation-chemotherapy of breast cancer stem cells.
    Xie X; Jiang K; Li B; Hou S; Tang H; Shao B; Ping Y; Zhang Q
    Biomaterials; 2022 Jul; 286():121598. PubMed ID: 35660821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy.
    Anees M; Mehrotra N; Tiwari S; Kumar D; Kharbanda S; Singh H
    Int J Pharm; 2023 Mar; 635():122779. PubMed ID: 36842520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in drug delivery systems for targeting cancer stem cells.
    Duan H; Liu Y; Gao Z; Huang W
    Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
    Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
    Front Immunol; 2021; 12():791551. PubMed ID: 35046949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
    Zhang Z; Deng Q; Xiao C; Li Z; Yang X
    Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma.
    Yang P; Zhang L; Wang T; Liu Q; Wang J; Wang Y; Tu Z; Lin F
    Onco Targets Ther; 2020; 13():8055-8067. PubMed ID: 32884291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer.
    Narvekar M; Xue HY; Tran NT; Mikhael M; Wong HL
    Eur J Pharm Biopharm; 2014 Sep; 88(1):226-37. PubMed ID: 24816129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.